Cancer Science · 2010 · 26 citations · 20 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCancer ProgressionColorectal CancerGrowth Factor SignalingMalignant NeoplasmsOncogenic Signaling PathwaysCancer Signaling PathwaysCell Cycle DynamicsCell Cycle InhibitionG0 Phase EntryG1 Phase ControlG1 Phase ProgressionTherapeutic Target Identification
Colon cancer is a leading cause of morbidity and mortality in Western countries. Basic fibroblast growth factor (bFGF) was up-regulated in patients with colon cancer and was considered as a potential therapeutic target. In this study, we first demonstrated that a novel bFGF-binding peptide (named P7) inhibited proliferation of several colon cancer cell lines including HT-29, LoVo, and Caco2 cells stimulated by bFGF. Further investigations with HT-29 cells indicated that P7 arrested the cell cycle at the G0/G1 phase of bFGF-stimulated cells, reduced the levels of phospho-Erk1/Erk2 induced by bFGF, and caused significant changes in the expression of proteins related to proliferation, cell cycle, and cancer. Our results suggested that the bFGF-binding peptide has a potential antitumor effect on colon cancer.
20
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
V. Neuhoff, Norbert Arold, Dieter Taube et al. · Electrophoresis · 1988 · 2.7K citations
Olivier E. Pardo, Alexandre Arcaro, Giovanni Salerno et al. · Journal of Biological Chemistry · 2015 · 153 citations · Full text